Susceptibility

In Vitro Activities of Voriconazole (UK-109,496) and Four Other Antifungal Agents against 394 Clinical Isolates ofCandida spp.

F. Marco, M. A. Pfaller, S. Messer, R. N. Jones
DOI: 10.1128/AAC.42.1.161

Article Information

DOI 
https://doi.org/10.1128/AAC.42.1.161
PubMed 
9449278
Published By 
American Society for Microbiology Journals
History 
  • Received August 1, 1997
  • Returned for modification September 26, 1997
  • Accepted October 13, 1997
  • Published online January 1, 1998.
Copyright & Usage 
Copyright © 1998 American Society for Microbiology

Author Information

  1. F. Marco†,
  2. M. A. Pfaller*,
  3. S. Messer and
  4. R. N. Jones
  1. 1Department of Pathology, University of Iowa College of Medicine, Iowa City, Iowa 52242

  • ↵* Corresponding author. Mailing address: Medical Microbiology Division, Department of Pathology, 606 GH, University of Iowa College of Medicine, Iowa City, IA 52242. Phone: (319) 384-9566. Fax: (319) 356-4916. E-mail:mpfaller{at}blue.weeg.uiowa.edu.

  • ↵† Present address: Microbiology Laboratory, Hospital Clinic, University of Barcelona, 08036-Barcelona, Spain.

Article usage

Article usage:

No statistics are available.
Back to top
Download PDF
Citation Tools
Print

Alerts
Email

KEYWORDS

antifungal agents
Candida
Pyrimidines
triazoles

Related Articles

Cited By...